Patent application number | Description | Published |
20100285751 | WIRELESS NETWORK CONNECTION SYSTEM AND METHOD USING INJECTION LOCKED OSCILLATORS - A wireless network connection system remotely connects to a network without the use of crystal reference oscillators. This provides communication at long range using a low transmit Effective Isotropic Radiated Power (EIRP). Operation is obtained through a combination of injection locking the system clock to the fundamental frequency of a remote reference oscillator, injection locking the transmitter to the third harmonic of the remote reference oscillator, a micro-watt RF receiver, and a network connection. | 11-11-2010 |
20110148580 | RFID TRANSPONDER USING AMBIENT RADIATION - A tag operates in an environment where transmitted interrogators are not possible or desired. High-efficiency diode rectifiers and low-power oscillators are used in combination with an energy storage element and hysteretic switch. The combination of multi-diode rectifier, low power tunnel diode oscillator, energy storage element and hysteretic switch allow for nanowatt levels of received RF power to be stored to produce micro-watts of RF transmit power. The device trickle charges off of ambient RF radiation until enough energy is stored for transmission. | 06-23-2011 |
20120136585 | METHOD AND SYSTEM FOR THE DETECTION AND IDENTIFICATION OF EXPLOSIVES AND/OR CONTRABAND - A nuclear quadrupole resonance system which senses the stimulated emission from target molecules includes in a calibration step and a stimulated emission response detection step, with the system employing clutter cancellation involving linear regression and the use of cross correlation with a series of known molecular signatures, both increasing the signal-to-noise ratio of the system. | 05-31-2012 |
20120161762 | LONG RANGE DETECTION OF EXPLOSIVES OR CONTRABAND USING NUCLEAR QUADRUPOLE RESONANCE - Nuclear quadrupole resonance substance detection at a distance is provided by crossed or overlapping high frequency beams in which the frequency of one of the beams is offset with respect to the frequency of the other beam by an amount equal to the resonant frequency of the non-linear material to be detected. The presence of energy at the offset frequency within the overlapping beams pumps any non-linear material within the overlapping beams to cause stimulated emission which is detected, in one embodiment, utilizing a network analyzer, along with correlation of the detected stimulated emission signature with a library of signatures for predetermined substances. | 06-28-2012 |
Patent application number | Description | Published |
20110177203 | GRANULATED MONOCALCIUM PHOSPHATE PRODUCT CONTAINING ABRASIVITY AND LUBRICITY ADDITIVES - A granulated monocalcium phosphate composition that provides sufficient nutritional value as well as enhanced pelleting benefits, such as abrasiveness and lubricity, compared to other granulated phosphate feed products. The granulated monocalcium phosphate composition includes one or more additives such as lubricity and abrasivity additives. The lubricity additive can include a sodium additive that lubricates the die during a feed milling or pelleting process. The abrasivity additive can include silica or sand that scours the die during the pelleting process. The increased lubricity and abrasivity attributes of the composition benefits die throughput and efficiency in the pelleting process, without compromising nutritional value in the final feed product. | 07-21-2011 |
20110177204 | GRANULATED MONOCALCIUM PHOSPHATE PRODUCT CONTAINING ABRASIVITY AND LUBRICITY ADDITIVES - A granulated monocalcium phosphate composition that provides sufficient nutritional value as well as enhanced pelleting benefits, such as abrasiveness and lubricity, compared to other granulated phosphate feed products. The granulated monocalcium phosphate composition includes one or more additives such as lubricity and abrasivity additives. The lubricity additive can include a sodium additive that lubricates the die during a feed milling or pelleting process. The abrasivity additive can include silica or sand that scours the die during the pelleting process. The increased lubricity and abrasivity attributes of the composition benefits die throughput and efficiency in the pelleting process, without compromising nutritional value in the final feed product. | 07-21-2011 |
20110293792 | GRANULATED PHOSPHATE PRODUCT CONTAINING ABRASIVITY AND LUBRICITY ADDITIVES - A granulated phosphate composition that provides sufficient nutritional value as well as enhanced pelleting benefits, such as abrasiveness and lubricity, compared to other granulated phosphate feed products. The granulated phosphate composition includes a phosphate source, such as monocalcium phosphate, mono-dicalcium phosphate, or dicalcium phosphate, and one or more additives such as lubricity and abrasivity additives. The lubricity additive can include a sodium additive that lubricates the die during a feed milling or pelleting process. The abrasivity additive can include silica or sand that scours the die during the pelleting process. The increased lubricity and abrasivity attributes of the composition benefits die throughput and efficiency in the pelleting process, without compromising nutritional value in the final feed product. | 12-01-2011 |
20140255549 | GRANULATED FEED PHOSPHATE COMPOSITION INCLUDING FEED ENZYMES - A granulated phosphate composition that provides sufficient nutritional value as well as enhanced bioavailability of organic phosphorous present in a main feed ingredient. The granulated phosphate composition includes a phosphate source, such as monocalcium phosphate, mono-dicalcium phosphate, or dicalcium phosphate, and one or more feed enzymes such as phytase. When the phosphate composition is compounded and pelleted with a main feed ingredient into a feed pellet, and consumed by a non-ruminant, the phytase component of the phosphate composition liberates otherwise unavailable phosphorous present in the main feed ingredient. | 09-11-2014 |
Patent application number | Description | Published |
20080227804 | Polymorphic Forms of Naltrexone - This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations. | 09-18-2008 |
20100286099 | INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE - A water-soluble aspirin-theanine cocrystal composition which includes a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer associated with the quantity of acetylsalicylic acid. The composition may be created by a method including the steps of: (i) providing a quantity of acetylsalicylic acid; (ii) adding a quantity of a theanine enantiomer to the quantity of acetylsalicylic acid to form a mixture comprising the quantity of acetylsalicylic acid and the enantiomer of theanine; (iii) wetting the mixture; and (iv) grinding the mixture for a length of time sufficient to produce a dried crystalline mass. The water-soluble cocrystal composition is suitable for intravenous administration, preferably to humans. | 11-11-2010 |
20120190655 | Intravenous Formulation with Water-Soluble CoCrystals of Acetylsalicylic Acid and Theanine - An aspirin-theanine cocrystal composition including a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer combined with the quantity of acetylsalicylic acid in a mixture. The theanine enantiomer may be L-theanine, D-theanine, or DL-theanine | 07-26-2012 |
20130012482 | INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE - A water-soluble cocrystal composition contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer selected from an alpha variant of theanine or a beta variant of theanine or other form of theanine. | 01-10-2013 |
20130253199 | Polymorphic Forms of Naltrexone - This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations. | 09-26-2013 |
20130345183 | INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE - A method of treating rheumatoid arthritis using a water-soluble cocrystal composition contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer selected from an alpha variant of theanine or a beta variant of theanine or other form of theanine. | 12-26-2013 |
20140148418 | INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE - A method of treating high grade temperature using a water-soluble cocrystal composition contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer selected from an alpha variant of theanine or a beta variant of theanine or other form of theanine. | 05-29-2014 |
20140171515 | COMPOSITIONS AND METHODS FOR TRANSMUCOSAL ABSORPTION - The invention provides compositions and methods for administering compounds for transmucosal absorption. The compositions and methods have a number of surprising pharmacokinetic benefits over oral administration of a compound. | 06-19-2014 |
20140179644 | INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE - A method of reducing hepatocellular damage in a subject using a water-soluble cocrystal composition which contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer. | 06-26-2014 |
20140235594 | INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE - A method of treating a condition associated with excess gluatame in a subject using a water-soluble cocrystal composition which contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer. | 08-21-2014 |
20140288029 | INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE - A method of treating myocardial infarction in a subject using a water-soluble cocrystal composition which contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer. | 09-25-2014 |
20140296189 | INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE - A method of reducing niacin flushing in a subject using a water-soluble cocrystal composition which contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer. | 10-02-2014 |
20140303200 | Polymorphic Forms of Naltrexone - This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations. | 10-09-2014 |
20140343021 | ADJUVANT TO THROMBOLYTIC THERAPY FOR THE TREATMENT OF FROSTBITE - A method of treating frostbite in a subject using a water-soluble cocrystal composition which contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer. | 11-20-2014 |
20150218178 | Polymorphic Forms Of Naltrexone - This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations. | 08-06-2015 |
Patent application number | Description | Published |
20110034558 | DP2 Antagonist and Uses Thereof - Described herein is the DP | 02-10-2011 |
20130041003 | Bendamustine Pharmaceutical Compositions - The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases. | 02-14-2013 |
20130053444 | DP2 ANTAGONIST AND USES THEREOF - Described herein is the DP | 02-28-2013 |
20130123316 | Bendamustine Pharmaceutical Compositions - The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases. | 05-16-2013 |
20130131131 | Bendamustine Pharmaceutical Compositions - The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases. | 05-23-2013 |
20130253023 | POLYCYCLIC LPA1 ANTAGONIST AND USES THEREOF - Described herein is the LPA1 antagonist 1-{4′-[3-methyl-4-((R)-1-phenyl-ethoxycarbonylamino)-isoxazol-5-yl]-bi-phenyl-4-yl}-cyclopropanecarboxylic acid (Compound 1), or pharmaceutically acceptable salts thereof. Also described are methods of preparing the LPA1 antagonist, or pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions suitable for administration to a mammal that include the LPA1 antagonist, or pharmaceutically acceptable salt thereof, and methods of using such pharmaceutical compositions for treating LPA-dependent or LPA-mediated diseases or conditions. | 09-26-2013 |
20130338205 | BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS - The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases. | 12-19-2013 |
20140148490 | BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS - The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases. | 05-29-2014 |
20150374671 | BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS - The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases. | 12-31-2015 |
Patent application number | Description | Published |
20080198602 | METHOD AND APPARATUS FOR ILLUMINATING MATERIAL FOR AUTOMATED INSPECTION - A lighting configuration that is a combination of far dark field lighting and a modified dark stripe lighting is disclosed. The novel combination provides a more robust detection of flaws on, e.g. a moving web of transparent film, than either would provide alone or through a summation of their individual parts. | 08-21-2008 |
20090030544 | MULTI-UNIT PROCESS SPATIAL SYNCHRONIZATION OF IMAGE INSPECTION SYSTEMS - A conversion control system is described that includes a database to store data defining a set of rules and an interface to receive local anomaly information from a plurality of different analysis machines associated with a plurality of manufacturing process lines that perform a plurality of operations on a web of material, and each of the manufacturing process lines includes position data for a set of regions on the web containing anomalies. The system also includes a computer that registers the position data of the local anomaly information for the plurality of manufacturing process lines to produce aggregate anomaly information. The system further includes a conversion control engine that applies the rules to the aggregate anomaly information to determine which anomalies represent actual defects in the web for a plurality of different products. | 01-29-2009 |
20130202200 | COMPUTER-AIDED ASSIGNMENT OF RATINGS TO DIGITAL SAMPLES OF A MANUFACTURED WEB PRODUCT - A computerized rating tool is described that assists a user in efficiently and consistently assigning expert ratings (i.e., labels) to a large collection of training images representing samples of a given product. The rating tool provides mechanisms for visualizing the training images in an intuitive and configurable fashion, including clustering and ordering the training images. In some embodiments, the rating tool provides an easy-to-use interface for exploring multiple types of defects represented in the data and efficiently assigning expert ratings. In other embodiments, the computer automatically assigns ratings (i.e., labels) to the individual clusters containing the large collection of digital images representing the samples. In addition, the computerized tool has capabilities ideal for labeling very large datasets, including the ability to automatically identify and select a most relevant subset of the images for a defect and to automatically propagate labels from this subset to the remaining images without requiring further user interaction. | 08-08-2013 |
20130236082 | RAPID PROCESSING AND DETECTION OF NON-UNIFORMITIES IN WEB-BASED MATERIALS - A computerized inspection system is described for detecting the presence of non-uniformity defects and providing output indicative of a severity of each type of non-uniformity defect. Techniques are described that increase the throughput of the inspection system. Algorithmic and hardware approaches are described to significantly decrease the average amount of time required to inspect a given quantity of material that is expected to be mostly uniform. The techniques described herein involve dynamic selection of which image features to compute by starting with a base feature set and only triggering additional feature computations as needed until the features are sufficient to compute a severity for each type of non-uniformity defect. The number of features extracted and the order in which the features are extracted is dynamically determined in real-time to reduce a cost associated with the feature extraction. | 09-12-2013 |
20130320994 | ELECTRODE TESTING APPARATUS - An apparatus to infer the resistivity of an electrode by stimulating the electrode with a capacitively coupled signal, and processing the resultant signal with circuitry that produces a signal having an amplitude that is a function of the resistivity of the electrode. | 12-05-2013 |
20130322733 | SYSTEM FOR DETECTION OF NON-UNIFORMITIES IN WEB-BASED MATERIALS - A system is described for detecting the presence of non-uniformity patterns and providing output indicative of a severity of each type of non-uniformity pattern. The system includes a computerized rating tool that assists a user in efficiently and consistently assigning expert ratings (i.e., labels) to a large collection of training images representing samples of a given product. In addition, the rating software develops a model that allows a computerized inspection system to detect the presence of non-uniformity patterns in a manufactured web material in real time and provide output indicative of a severity level of each pattern on a continuous scale. The system also includes algorithmic and hardware approaches to significantly that increase the throughput of the inspection system. | 12-05-2013 |
Patent application number | Description | Published |
20080293615 | Dimensionally Stable Solid Rinse Aid - The present invention is a solid rinse aid composition and methods of making and using the same. The solid rinse aid composition generally includes sodium sulfate and urea as solidification agents and an effective amount of an alcohol ethoxylate compound sheeting agent component and an effective amount of defoamer component. The solid rinse aid composition may also incorporate a preservative system including sodium bisulfate. The solid rinse aid composition may be phosphate-free, aminocarboxylate-free, and GRAS if desired. | 11-27-2008 |
20090203569 | DIMENSIONALLY STABLE SOLID RINSE AID - The present invention is a solid rinse aid composition and methods of making and using the same. The solid rinse aid composition generally includes sodium sulfate and urea as solidification agents and an effective amount of an alcohol ethoxylate compound sheeting agent component and an effective amount of defoamer component. The solid rinse aid composition may also incorporate a preservative system including sodium bisulfate. The solid rinse aid composition may be phosphate-free, aminocarboxylate-free, and GRAS if desired. | 08-13-2009 |
20120231992 | DIMENSIONALLY STABLE SOLID RINSE AID - The present invention is a solid rinse aid composition and methods of making and using the same. The solid rinse aid composition generally includes sodium sulfate and urea as solidification agents and an effective amount of an alcohol ethoxylate compound sheeting agent component and an effective amount of defoamer component. The solid rinse aid composition may also incorporate a preservative system including sodium bisulfate. The solid rinse aid composition may be phosphate-free, aminocarboxylate-free, and GRAS if desired. | 09-13-2012 |
20140069466 | METHOD OF REDUCING SOIL REDEPOSITION ON A HARD SURFACE USING PHOSPHINOSUCCINIC ACID ADDUCTS - Methods employing detergent compositions effective for reducing soil redeposition and accumulation on hard surfaces are disclosed. The detergent compositions employ phosphinosuccinic acid adducts in combination with an alkalinity source and gluconic acid or salts thereof, copolymers of acrylic acid and maleic acids or salts thereof, sodium hypochlorite, sodium dichloroisocyanurate or combinations thereof. | 03-13-2014 |
Patent application number | Description | Published |
20090190427 | System to Enable a Memory Hub Device to Manage Thermal Conditions at a Memory Device Level Transparent to a Memory Controller - A memory system is provided that manages thermal conditions at a memory device level transparent to a memory controller. The memory systems comprises a memory hub device integrated in a memory module, a set of memory devices coupled to the memory hub device, and a first set of thermal sensors integrated in the set of memory devices. A thermal management control unit integrated in the memory hub device monitors a temperature of the set of memory devices sensed by the first set of thermal sensors. The memory hub device reduces a memory access rate to the set of memory devices in response to a predetermined thermal threshold being exceeded thereby reducing power used by the set of memory devices which in turn decreases the temperature of the set of memory devices. | 07-30-2009 |
20090190429 | System to Provide Memory System Power Reduction Without Reducing Overall Memory System Performance - A memory system is provided that provides memory system power reduction without reducing overall memory system performance. The memory system comprises a memory hub device integrated in a memory module. The memory hub device comprises a command queue that receives a memory access command from an memory controller via a memory channel at a first operating frequency. The memory system also comprises a memory hub controller integrated in the memory hub device. The memory hub controller reads the memory access command from the command queue at a second operating frequency. By receiving the memory access command at the first operating frequency and reading the memory access command at the second operating frequency an asynchronous boundary is implemented. Using the asynchronous boundary, the memory channel operates at a maximum designed operating bandwidth while the second operating frequency is independently decreased to reduce power being consumed by the set of memory devices. | 07-30-2009 |
20090193200 | System to Support a Full Asynchronous Interface within a Memory Hub Device - A memory system is provided that implements an asynchronous boundary in a memory module. The memory system comprises a memory hub device integrated in a memory module. The memory system also comprises a set of memory devices coupled to the memory hub device. The memory hub device comprises a command queue that receives a memory access command from an external memory controller via a memory channel at a first operating frequency. The memory system further comprises a memory hub controller integrated in the memory hub device. The memory hub controller reads the memory access command from the command queue at a second operating frequency. By receiving the memory access command at the first operating frequency and reading the memory access command at the second operating frequency an asynchronous boundary is implemented within the memory hub device of the memory module. | 07-30-2009 |
20090193201 | System to Increase the Overall Bandwidth of a Memory Channel By Allowing the Memory Channel to Operate at a Frequency Independent from a Memory Device Frequency - A memory system is provided that increases the overall bandwidth of a memory channel by operating the memory channel at a independent frequency. The memory system comprises a memory hub device integrated in a memory module. The memory hub device comprises a command queue that receives a memory access command from an external memory controller via a memory channel at a first operating frequency. The memory system also comprises a memory hub controller integrated in the memory hub device. The memory hub controller reads the memory access command from the command queue at a second operating frequency. By receiving the memory access command at the first operating frequency and reading the memory access command at the second operating frequency an asynchronous boundary is implemented. Using the asynchronous boundary, the memory channel operates at a maximum designed operating bandwidth, which is independent of the second operating frequency. | 07-30-2009 |
20090193203 | System to Reduce Latency by Running a Memory Channel Frequency Fully Asynchronous from a Memory Device Frequency - A memory system is provided that reduces latency by running a memory channel fully asynchronous from a memory device frequency. The memory system comprises a memory hub device integrated in a memory module. The memory hub device comprises a command queue that receives a memory access command from an external memory controller via a memory channel at a first operating frequency. The memory system also comprises a memory hub controller integrated in the memory hub device. The memory hub controller reads the memory access command from the command queue at a second operating frequency. By receiving the memory access command at the first operating frequency and reading the memory access command at the second operating frequency an asynchronous boundary is implemented. The first operating frequency is a maximum designed operating frequency of the memory channel and the first operating frequency is independent of the second operating frequency. | 07-30-2009 |
20130117513 | MEMORY QUEUE HANDLING TECHNIQUES FOR REDUCING IMPACT OF HIGH LATENCY MEMORY OPERATIONS - Techniques for handling queuing of memory accesses prevent passing excessive requests that implicate a region of memory subject to a high latency memory operation, such as a memory refresh operation, memory scrubbing or an internal bus calibration event, to a re-order queue of a memory controller. The memory controller includes a queue for storing pending memory access requests, a re-order queue for receiving the requests, and a control logic implementing a queue controller that determines if there is a collision between a received request and an ongoing high-latency memory operation. If there is a collision, then transfer of the request to the re-order queue may be rejected outright, or a count of existing queued operations that collide with the high latency operation may be used to determine if queuing the new request will exceed a threshold number of such operations. | 05-09-2013 |
20130138878 | Method for Scheduling Memory Refresh Operations Including Power States - A method for performing refresh operations on a rank of memory devices is disclosed. After the completion of a memory operation, a determination is made whether or not a refresh backlog count value is less than a predetermined value and the rank of memory devices is being powered down. If the refresh backlog count value is less than the predetermined value and the rank of memory devices is being powered down, an Idle Count threshold value is set to a maximum value such that a refresh operation will be performed after a maximum delay time. If the refresh backlog count value is not less than the predetermined value or the rank of memory devices is not in a powered down state, the Idle Count threshold value is set based on the slope of an Idle Delay Function such that a refresh operation will be performed accordingly. | 05-30-2013 |
20130173858 | Method for Scheduling Memory Refresh Operations Including Power States - A method for performing refresh operations on a rank of memory devices is disclosed. After the completion of a memory operation, a determination is made whether or not a refresh backlog count value is less than a predetermined value and the rank of memory devices is being powered down. If the refresh backlog count value is less than the predetermined value and the rank of memory devices is being powered down, an Idle Count threshold value is set to a maximum value such that a refresh operation will be performed after a maximum delay time. If the refresh backlog count value is not less than the predetermined value or the rank of memory devices is not in a powered down state, the Idle Count threshold value is set based on the slope of an Idle Delay Function such that a refresh operation will be performed accordingly. | 07-04-2013 |
20140052936 | MEMORY QUEUE HANDLING TECHNIQUES FOR REDUCING IMPACT OF HIGH-LATENCY MEMORY OPERATIONS - Techniques for handling queuing of memory accesses prevent passing excessive requests that implicate a region of memory subject to a high latency memory operation, such as a memory refresh operation, memory scrubbing or an internal bus calibration event, to a re-order queue of a memory controller. The memory controller includes a queue for storing pending memory access requests, a re-order queue for receiving the requests, and a control logic implementing a queue controller that determines if there is a collision between a received request and an ongoing high-latency memory operation. If there is a collision, then transfer of the request to the re-order queue may be rejected outright, or a count of existing queued operations that collide with the high latency operation may be used to determine if queuing the new request will exceed a threshold number of such operations. | 02-20-2014 |